Jan 6
|
Why Is AstraZeneca PLC (NASDAQ:AZN) Among the Best FTSE Dividend Stocks to Buy Now?
|
Jan 6
|
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
|
Jan 4
|
Better Buy: Novo Nordisk vs. AstraZeneca
|
Jan 3
|
China’s NMPA prioritises HUTCHMED’s lung cancer therapy review
|
Jan 3
|
The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer
|
Jan 2
|
MNPR Stock Skyrockets 384% in 3 Months After Deal With AZN
|
Jan 2
|
5 Large Drug Stocks to Keep An Eye On in the New Year
|